INVVY News and Press, Indivior PLC ADR From 12/20/18

WARREN, N.J. , Dec. 20, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a specialty pharmaceutical company pharmaceutical company focused on identifying, developing, and commercializing differentiated products to solve therapeutic problems, is reporting positive dev...

CUPERTINO, Calif. , Dec. 19, 2018 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Indivior PLC (LON: INDV) stated on December 18, 2018 that it is moving ahead with the launch of PERSERIS™ in the U.S. with a sales force consisting of approximately ...

The following slide deck was published by INDIVIOR PLC ADR in conjunction with this Read more ...

CBS' 60 Minutes will air a segment this Sunday featuring Ohio governor-elect Mike DeWine (formerly the AG) criticizing certain drug companies and distributors over their role in the opioid crisis. According to reporter Bill Whitaker, Mr. DeWine says the evidence, obtained from the confiden...

SLOUGH, England, Dec. 12, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) has denied Dr. Reddy's Laboratories (DRL's) motion to immediately issue the mandate following the CAFC's ...

SLOUGH, England , Nov. 27, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that in light of the recent decision by the Court of Appeals for the Federal Circuit (CAFC) vacating the preliminary injunction against Dr. Reddy's Laboratories (DRL) the...

Indivior ( OTCPK:INVVY )  rises 4.2%  after Health Canada approves Sublocade buprenorphine extended-release injection for the managing moderate to severe opioid use disorder. More news on: INDIVIOR PLC ADR, Healthcare stocks news, Stocks on the move, Read more ...

SUBLOCADE is the first and only once-monthly injectable buprenorphine formulation approved in Canada for the management of moderate to severe opioid use disorder SLOUGH, England and RICHMOND, Va. , Nov. 23, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) today ...

Indivior PLC ( OTCPK:INVVY ) sinks 12%  after a U.S. appeals court vacates a preliminary injunction that had prevented Dr. Reddy's Laboratories ( RDY +0.7% ) from selling a generic version of Suboxone, Indivior's product that used to treat opioid dependence. More news on: INDIVIO...

SLOUGH, England , Nov. 21, 2018 /PRNewswire/ -- Indivior PLC (LON: INDV) ("Indivior" or the "Company") today announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated the preliminary injunction (PI) previously granted against Dr. Reddy's Laboratories (DRL) by...